Peter DeYoung, CEO at Piramal Pharma Limited, explains how Piramal is meeting the growing demand for integrated biologics ...

Both companies viewed the early end to the PIVOT-PO trial as a positive development, with GSK saying it would work with US ...

Pharmaceutical Technology® spoke with Martin Meeson, CEO of Axplora, about the role contract development and manufacturing ...

In this podcast episode, we discuss novel approaches to drug delivery, specifically regarding adeno-associated virus (AAV) ...

Teva’s investigational monoclonal antibody, TEV-53408, has been designed for use in adults with celiac disease, for which a ...

In discussions at INTERPHEX 2025, company representatives seized upon several common themes, most notably safety, ...

Global scale-up requires developing replicable processes that work the same no matter where they are performed. This can be ...

Leveraging computerized maintenance management systems software can enhance efficiency, improve quality control, ensure ...

The concerns of industry experts expressed at INTERPHEX in April 2025 are still pertinent in an uncertain global political ...

Christy Eatmon of Thermo Fisher Scientific reviewed her company’s experience at CPHI Americas 2025 and discussed recent industry trends that are driving strategic partnerships.

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

MHRA approves Loba Biotech to manufacture Pegasys API, enabling pharma& to strengthen UK supply and ensure continued access for eligible patients.